Edesa Biotech (EDSA)
Develops clinical candidates for inflammatory and immune-related diseases.
$4.77
At close−0.01 (−0.21%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions27 holders · as of Mar 31, 2026 | 27.42% | 2.64M shares | |
| Insiders10 holders · as of Sep 1, 2026 | 20.44% | 1.97M shares | |
| Strategic holders1 holder · as of Jun 18, 2026 | 5.40% | 520.7K shares | |
| Otherremainder | 46.74% | 4.51M shares |
9.64M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
27 holders · 2.64M shares · 15 new positions · 19 increased · 2 reduced · 9 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Velan Capital Investment Management LP | 827.5K | 8.58% | +140.0K | May 15, 2026 |
| Rubric Capital Management LP | 687.5K | 7.13% | 0 | May 15, 2026 |
| Perceptive Advisors LLC | 563.2K | 5.84% | +563.2Knew | May 29, 2026 |
| Jane Street Group, LLC | 115.7K | 1.20% | +115.7Knew | May 12, 2026 |
| Vanguard Capital Management LLC | 86.0K | 0.89% | +86.0Knew | May 15, 2026 |
| Geode Capital Management, LLC | 77.1K | 0.80% | +30.5K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 38.4K | 0.40% | +38.4Knew | May 8, 2026 |
| State Street Corp | 38.0K | 0.39% | +19.3K | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Pardeep Nijhawanincl. The Digestive Health Clinic Inc., The New Nijhawan Family Trust 2015 +2 more | 16.31% | 2.61M | 13D | Aug 25, 2026 ↗ |
| Velan Capital Management LLCincl. Velan Horizon GP LLC, Velan Capital Master Fund LP +6 more | 9.99% | 1.36M | 13D | Aug 25, 2026 ↗ |
| Rubric Capital Management LP | 7.74% | 687.5K | 13G | May 15, 2026 ↗ |
| Sirenia Capital Management LP | 7.20% | 600.0K | 13G | May 15, 2026 ↗ |
| Stonepine Capital Management, LLC | 6.90% | 953.7K | 13G | Aug 26, 2026 ↗ |
| Perceptive Advisors LLC | 6.70% | 563.2K | 13G | Mar 16, 2026 ↗ |
| Integrated Core Strategies (US) LLC | 5.40% | 520.7K | 13G | Jun 18, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Feb 26, 2026 | Michael J. Brooksofficer: President | Purchase | 2,000 | $1.57 | 226,870 |
| Mar 5, 2026 | Pardeep Nijhawandirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 10,000 | $3.90 | 402,702 |
| Mar 4, 2026 | Pardeep Nijhawandirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 10,000 | $4.26 | 392,702 |
| Mar 3, 2026 | Pardeep Nijhawandirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 10,000 | $3.63 | 382,702 |
| Mar 2, 2026 | Pardeep Nijhawandirector, 10 percent owner, officer: Chief Executive Officer | Purchase · 2 lots | 3,000 | $2.09 | 1,000,515 |
| Feb 27, 2026 | Pardeep Nijhawandirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 30,000 | $2.22 | 371,702 |
| Feb 26, 2026 | Pardeep Nijhawandirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 20,571 | $1.58 | 615,797 |
CongressHouse and Senate disclosures
Not reported.